Biotech

All Articles

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Lykos will ask FDA to reconsider its own choice adhering to denial of MDMA treatment for post-traumatic stress disorder

.Adhering to a poor showing for Lykos Therapies' MDMA candidate for post-traumatic stress disorder a...

AN 2 one-halfs census, stops phase 3 trial after data dissatisfy

.AN2 Rehabs is reconsidering its service in reaction to lackluster midphase data, vowing to lay off ...

Merck spends $700M for bispecific, snooping autoimmune opening as well as odds to test Amgen in cancer

.Merck &amp Co. is spending $700 million beforehand to test Amgen in a blood stream cancer market. T...

Gilead pays for J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its liver ailment medicine seladelpa...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks can see the providers establishing outdoors tents at basecamp responsible for Eli L...

Entero giving up workers, vacating office as well as stopping briefly R&ampD

.Mattress Liquidators has switched Entero Therapies white as a slab. The creditor bought Entero to r...

Exelixis loses ADC after choosing it is actually no suit for Tivdak

.Exelixis is actually giving up on its cells factor (TF)- targeting antibody-drug conjugate after co...

Relay dislikes SHP2 inhibitor after Genentech leaves

.3 weeks after Roche's Genentech unit walked away from an SHP2 prevention deal, Relay Rehab has veri...

Stoke's Dravet disorder med launched of partial scientific hold

.Stoke Rehabs' Dravet disorder medication has actually been devoid of a predisposed grip, getting ri...